Compass Therapeutics Inc.

General ticker "CMPX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $212.7M

Compass Therapeutics Inc. follows the US Stock Market performance with the rate: 11.2%.

Estimated limits based on current volatility of 4.9%: low 1.36$, high 1.50$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.97$, 2.39$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.87$, 2.12$]

Financial Metrics affecting the CMPX estimates:

  • Negative: Non-GAAP EPS, $ of -0.34 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -16.21 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term CMPX quotes

Long-term CMPX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $81.88MM $41.66MM $50.36MM
Operating Income $-81.88MM $-41.66MM $-50.36MM
Non-Operating Income $-0.30MM $2.43MM $7.87MM
Interest Expense $0.37MM $2.36MM $0.00MM
R&D Expense $20.34MM $30.00MM $37.42MM
Income(Loss) $-82.18MM $-39.23MM $-42.49MM
Profit(Loss) $-82.18MM $-39.23MM $-42.49MM
Stockholders Equity $140.08MM $181.64MM $148.54MM
Assets $153.76MM $199.65MM $156.88MM
Operating Cash Flow $-19.67MM $-34.12MM $-40.62MM
Capital expenditure $1.57MM $0.21MM $0.03MM
Investing Cash Flow $-1.77MM $-151.20MM $26.96MM
Financing Cash Flow $118.61MM $75.76MM $2.94MM
Earnings Per Share* $-1.31 $-0.35 $-0.33

* EPS are Split Adjusted, recent splits may be reflected with a delay.